Akers Biosciences' IPO

Akers Biosciences raised a round of funding on January 23, 2014. Investors include Public.

Akers Biosciences (ABI) develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a …

Articles about Akers Biosciences' IPO: